Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

N Sharifi

Showing results (51-60 of 65) with videos related to

Pageof 7
Sort By:
Biorxiv : the Preprint Server for Biology|June 10, 2024
Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S <i>ESR1</i> Mutant Breast Cancer CellsK S Young, G R Hancock, E Fink, et al.
NPJ Precision Oncology|October 2, 2024
A phenocopy signature of TP53 loss predicts response to chemotherapyHamza Bakhtiar, Marina N Sharifi, Kyle T Helzer, et al.
Oncogene|April 23, 2013
The role of DAB2IP in androgen receptor activation during prostate cancer progressionK Wu, J Liu, S-F Tseng, et al.
Breast Cancer Research : BCR|January 17, 2025
Targeting unique ligand binding domain structural features downregulates DKK1 in Y537S ESR1 mutant breast cancer cellsK S Young, G R Hancock, E C Fink, et al.
Communications Biology|March 14, 2024
A platform-independent AI tumor lineage and site (ATLAS) classifierNicholas R Rydzewski, Yue Shi, Chenxuan Li, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
OGDHL regulates nucleotide metabolism, tumor growth, and neuroendocrine marker expression in prostate cancerMatthew J Bernard, Angel Ruiz, Johnny A Diaz, et al.
JCI Insight|September 24, 2024
Clinical cell-surface targets in metastatic and primary solid cancersMarina N Sharifi, Yue Shi, Matthew R Chrostek, et al.
Molecular Oncology|February 22, 2025
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancerMarina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
Molecular Cancer Research : MCR|January 27, 2026
OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundanceMatthew J Bernard, Andrea Gallardo, Angel Ruiz, et al.
Pageof 7

Showing results (51-60 of 65) with videos related to

Sort By:
Pageof 7
Biorxiv : the Preprint Server for Biology|June 10, 2024
Targeting Unique Ligand Binding Domain Structural Features Downregulates DKK1 in Y537S <i>ESR1</i> Mutant Breast Cancer CellsK S Young, G R Hancock, E Fink, et al.
NPJ Precision Oncology|October 2, 2024
A phenocopy signature of TP53 loss predicts response to chemotherapyHamza Bakhtiar, Marina N Sharifi, Kyle T Helzer, et al.
Oncogene|April 23, 2013
The role of DAB2IP in androgen receptor activation during prostate cancer progressionK Wu, J Liu, S-F Tseng, et al.
Breast Cancer Research : BCR|January 17, 2025
Targeting unique ligand binding domain structural features downregulates DKK1 in Y537S ESR1 mutant breast cancer cellsK S Young, G R Hancock, E C Fink, et al.
Communications Biology|March 14, 2024
A platform-independent AI tumor lineage and site (ATLAS) classifierNicholas R Rydzewski, Yue Shi, Chenxuan Li, et al.
Biorxiv : the Preprint Server for Biology|June 12, 2025
OGDHL regulates nucleotide metabolism, tumor growth, and neuroendocrine marker expression in prostate cancerMatthew J Bernard, Angel Ruiz, Johnny A Diaz, et al.
JCI Insight|September 24, 2024
Clinical cell-surface targets in metastatic and primary solid cancersMarina N Sharifi, Yue Shi, Matthew R Chrostek, et al.
Molecular Oncology|February 22, 2025
Adverse prognosis gene expression patterns in metastatic castration-resistant prostate cancerMarina N Sharifi, Eric Feng, Nicholas R Rydzewski, et al.
Nature Communications|October 14, 2025
Analysis of cfDNA fragmentomics metrics and commercial targeted sequencing panelsKyle T Helzer, Marina N Sharifi, Jamie M Sperger, et al.
Molecular Cancer Research : MCR|January 27, 2026
OGDHL promotes prostate cancer progression and regulates neuroendocrine marker expression and nucleotide abundanceMatthew J Bernard, Andrea Gallardo, Angel Ruiz, et al.
Pageof 7